Ticker
GOSSCompany Name
GOSSAMER BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 240.93M | $ 201.94M | 83.82% |
3/31/2025 | $ 280.59M | $ 201.93M | 71.97% |
12/31/2024 | $ 315.29M | $ 201.92M | 64.04% |
9/30/2024 | $ 350.88M | $ 201.88M | 57.53% |
6/30/2024 | $ 373.45M | $ 197.05M | 52.77% |
3/31/2024 | $ 259.36M | $ 206.41M | 79.58% |
12/31/2023 | $ 311.92M | $ 209.16M | 67.06% |
9/30/2023 | $ 347.93M | $ 212.6M | 61.11% |
6/30/2023 | $ 181.75M | $ 216.02M | 118.86% |
3/31/2023 | $ 219.91M | $ 219.4M | 99.77% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for GOSSAMER BIO INC is calculated as follows: Debt [ $ 179.47M ] / Assets [ $ 584.18M ]
(=) Debt to Assets [ 30.72% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.32% |
median | 21.04% |
std | 24.51% |